Normal-Sized Needles Segment to Hold Largest Share of Intradermal Injection Market During 2021-2028

According to our latest study on "Intradermal Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Method, Application, and End User," the market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to grow at a CAGR of 11.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Over the past two decades, there has been an unprecedented surge in the demand for intradermal injections due to rising incidence of various diseases and increasing acceptance of intradermal vaccination and aesthetic procedures. Moreover, there is an increasing demand for less invasive intradermal devices such as intradermal jet injectors, microinjections, and ballistic intradermal injections. As per the WHO's data, tuberculosis is the 13th leading cause of death and about 10 million cases of TB have been recorded every year. A sudden rise in the diagnostic rate of TB has been observed during the last decade, which is one of the leading reasons for the increasing market size of tuberculin syringes. Moreover, the number of aesthetic procedures is increasing rapidly in North American and European countries. Further, the availability of intradermal influenza vaccine, hepatitis vaccine, and smallpox vaccine is also boosting the intradermal injections market; also, the availability of COVID-19 intradermal vaccine in the clinical pipeline of various companies is expected to further trigger the growth rate of this market.

Based on application, the intradermal injection market is segmented tuberculin skin testing, allergy test, local aesthetics, and others. In 2021, the tuberculin skin testing segment would hold the largest share of the market, while the local aesthetic segment is expected to register the highest CAGR in the market during 2021-2028.

Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices are among the leading companies operating in the intradermal injection market.

Report Segments Intradermal Injection Market as Follows:

The intradermal Injection market is segmented on the basis of method, application, and end user. Based on method, the market is segmented into normal-sized needles, short needles, and without needles. Based on application, the market is segmented into tuberculin skin testing, allergy testing, local aesthetics, and others. Based on the end user, the market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. On the basis of geography, the intradermal injection market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com